Furthermore, the investigators reported repressed hepatic expression of JMJD3, ATG7, LC3 and ULK1 in MASLD patients, and with the exception of ATG7, our data for MASLD patients agreed with their findings. Here, KDM6B is linked to metabolic dysfunction-associated steatotic liver disease.